Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs
- 11 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 22 (2), 693-702
- https://doi.org/10.1007/s00198-010-1268-4
Abstract
The goal of this study was to document how treatment with high doses of zoledronic acid affects dental extraction healing. Our results, showing significantly compromised osseous healing within the socket as well as presence of exposed bone and development of a sequestrum in one animal, provide a building block toward understanding osteonecrosis of the jaw. The goal of this study was to document how treatment with a bisphosphonate affects the bone tissue following dental extraction. Skeletally mature female beagle dogs were either untreated controls (CON) or treated with intravenous zoledronic acid (ZOL). Following the extraction of the fourth premolars, healing was allowed for 4 or 8 weeks. Properties of the extraction site were assessed using microcomputed tomography (micro-CT) and dynamic histomorphometry. The initial infilling of the extraction socket with bone was not affected by ZOL, but subsequent removal of this bone was significantly suppressed compared to CON. After 8 weeks of healing, the alveolar cortical bone adjacent to the extraction socket had a remodeling rate of ∼50% per year in CON animals while ZOL-treated animals had a rate of <1% per year. One ZOL-treated animal developed exposed bone post-extraction which eventually led to the formation of a sequestrum. Assessment of the sequestrum with micro-CT and histology showed that it had features consistent with those reported in humans with osteonecrosis of the jaw. These results, showing significantly compromised post-extraction osseous healing as well as presence of exposed bone and development of a sequestrum in one ZOL animal, provide a building block toward understanding the pathophysiology of osteonecrosis of the jaw.Keywords
This publication has 38 references indexed in Scilit:
- Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw–like disease in miceJournal of Bone and Mineral Research, 2010
- Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in ratsJournal of Bone and Mineral Research, 2010
- Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogsJournal of Bone and Mineral Research, 2010
- Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the JawJournal of Clinical Oncology, 2009
- Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in miceJournal of Bone and Mineral Metabolism, 2009
- Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in ratsJournal of Bone and Mineral Metabolism, 2009
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008
- Mandible Matrix Necrosis in Beagle Dogs After 3 Years of Daily Oral Bisphosphonate TreatmentJournal of Oral and Maxillofacial Surgery, 2008
- The effect of alendronate on resorption of the alveolar bone following tooth extractionInternational Journal of Oral & Maxillofacial Surgery, 2004
- The progress of the periodontal syndrome in the rice ratJournal of Periodontal Research, 1981